Research explores patient comprehension of preemptive pharmacogenomic results, suggesting implications for medication safety.
Background Preemptive pharmacogenomic (PGx) testing is a candidate for broad implementation because of its potential to improve medication safety and outcomes. However, little is known about how patients may process preemptively generated PGx information.
No takes yet. Share an insight, caveat, or question.
Pacyna et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: